Literature DB >> 8371219

Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus.

P E Carreira1, F Gutierrez-Larraya, J J Gomez-Reino.   

Abstract

We describe a case of successful intrauterine treatment with dexamethasone for fetal carditis in a woman with systemic lupus erythematosus. Targeted dual M-mode fetal echocardiogram showed disappearance of pericardial effusion and heart failure with therapy. The maternofetal pair had several of the factors considered a risk for passively transmitted autoimmune carditis. Our case further supports the evidence that dexamethasone could be effective for intrauterine treatment of this clinical situation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371219

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Congenital complete heart block.

Authors:  B Agarwala; Z Sheikh; L A Cibils
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

Review 2.  Lupus pregnancies and neonatal lupus.

Authors:  M D Lockshin
Journal:  Springer Semin Immunopathol       Date:  1994

Review 3.  Autoantibody-associated congenital heart block: the clinical perspective.

Authors:  Jill P Buyon; Deborah M Friedman
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

4.  Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.

Authors:  L Strandberg; O Winqvist; S-E Sonesson; S Mohseni; S Salomonsson; K Bremme; J P Buyon; H Julkunen; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

Review 5.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.